Use of simeprevir following pre‐emptive pegylated interferon/ribavirin treatment for recurrent hepatitis C in living donor liver transplant recipients: a 12‐week pilot study
Published in
Journal of Hepato-Biliary-Pancreatic Sciences, October 2014
This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 December 2017.
All research outputs
#4,617,386
of 34,360,257 outputs
Outputs from Journal of Hepato-Biliary-Pancreatic Sciences
#84
of 876 outputs
Outputs of similar age
#43,641
of 307,496 outputs
Outputs of similar age from Journal of Hepato-Biliary-Pancreatic Sciences
#4
of 21 outputs
Altmetric has tracked 34,360,257 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 876 research outputs from this source. They receive a mean Attention Score of 4.6. This one has done particularly well, scoring higher than 90% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 307,496 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 85% of its contemporaries.
We're also able to compare this research output to 21 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 80% of its contemporaries.